US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.4570
+0.0170+3.86%

Close Jul 26 16:00 ET

0.4569
-0.0001-0.02%

Pre 08:52 ET

39.16MMarket Cap-496P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-29.02%675K

675K

951K

Operating revenue

--0

-29.02%675K

--0

--675K

--951K

--0

--951K

--0

Cost of revenue

Gross profit

Operating expense

88.72%9.2M

12.87%21.45M

18.55%6.31M

-8.72%5.94M

18.87%4.32M

37.89%4.88M

111.69%19M

93.50%5.33M

37.96%6.51M

366.75%3.64M

Selling and administrative expenses

29.45%2.39M

30.15%8.55M

40.07%2.08M

50.76%2.57M

15.71%2.06M

15.15%1.85M

126.68%6.57M

6.76%1.49M

81.26%1.7M

520.98%1.78M

-General and administrative expense

29.45%2.39M

30.15%8.55M

40.07%2.08M

50.76%2.57M

15.71%2.06M

15.15%1.85M

126.68%6.57M

6.76%1.49M

81.26%1.7M

520.98%1.78M

Research and development costs

124.85%6.81M

3.75%12.9M

10.23%4.23M

-29.79%3.37M

21.88%2.27M

56.75%3.03M

104.54%12.44M

182.15%3.84M

27.20%4.8M

277.28%1.86M

Operating profit

-119.04%-9.2M

-15.08%-20.77M

-18.55%-6.31M

-6.91%-5.94M

-18.87%-4.32M

-18.80%-4.2M

-101.09%-18.05M

-93.50%-5.33M

-17.79%-5.55M

-366.75%-3.64M

Net non-operating interest income expense

2,350.00%49K

8,983.33%533K

4,133.33%121K

7,066.67%209K

202K

99.04%-6K

-3K

94.55%-3K

Non-operating interest income

392.86%69K

--615K

--140K

--227K

--234K

--14K

--0

Non-operating interest expense

66.67%20K

1,266.67%82K

533.33%19K

500.00%18K

--32K

--12K

-99.04%6K

--3K

-94.55%3K

--0

Other net income (expense)

-13.81%-11.81M

-10.3M

-1.61M

1.4M

282K

-10.38M

Gain on sale of security

-13.81%-11.81M

---10.3M

---1.61M

--1.4M

--282K

---10.38M

----

Income before tax

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Income tax

Net income

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Net income continuous Operations

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Minority interest income

Net income attributable to the parent company

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Preferred stock dividends

8.33%208K

867K

72K

603K

192K

Other preferred stock dividends

Net income attributable to common stockholders

-43.37%-21.17M

-73.95%-31.41M

-46.36%-7.8M

20.73%-4.41M

-22.14%-4.44M

-317.50%-14.77M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Basic earnings per share

37.11%-0.61

-6.67%-1.28

54.29%-0.16

64.86%-0.13

-20.83%-0.29

-304.17%-0.97

-39.53%-1.2

-105.88%-0.35

0.00%-0.37

-205.03%-0.24

Diluted earnings per share

37.11%-0.61

-6.67%-1.28

54.29%-0.16

64.86%-0.13

-20.83%-0.29

-304.17%-0.97

-39.53%-1.2

-105.88%-0.35

0.00%-0.37

-205.03%-0.24

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-29.02%675K	0	0	0	675K	951K	0	951K	0
Operating revenue	--0	-29.02%675K	--0	--0	--0	--675K	--951K	--0	--951K	--0
Cost of revenue
Gross profit
Operating expense	88.72%9.2M	12.87%21.45M	18.55%6.31M	-8.72%5.94M	18.87%4.32M	37.89%4.88M	111.69%19M	93.50%5.33M	37.96%6.51M	366.75%3.64M
Selling and administrative expenses	29.45%2.39M	30.15%8.55M	40.07%2.08M	50.76%2.57M	15.71%2.06M	15.15%1.85M	126.68%6.57M	6.76%1.49M	81.26%1.7M	520.98%1.78M
-General and administrative expense	29.45%2.39M	30.15%8.55M	40.07%2.08M	50.76%2.57M	15.71%2.06M	15.15%1.85M	126.68%6.57M	6.76%1.49M	81.26%1.7M	520.98%1.78M
Research and development costs	124.85%6.81M	3.75%12.9M	10.23%4.23M	-29.79%3.37M	21.88%2.27M	56.75%3.03M	104.54%12.44M	182.15%3.84M	27.20%4.8M	277.28%1.86M
Operating profit	-119.04%-9.2M	-15.08%-20.77M	-18.55%-6.31M	-6.91%-5.94M	-18.87%-4.32M	-18.80%-4.2M	-101.09%-18.05M	-93.50%-5.33M	-17.79%-5.55M	-366.75%-3.64M
Net non-operating interest income expense	2,350.00%49K	8,983.33%533K	4,133.33%121K	7,066.67%209K	202K	2K	99.04%-6K	-3K	94.55%-3K	0
Non-operating interest income	392.86%69K	--615K	--140K	--227K	--234K	--14K	--0	--0	--0	--0
Non-operating interest expense	66.67%20K	1,266.67%82K	533.33%19K	500.00%18K	--32K	--12K	-99.04%6K	--3K	-94.55%3K	--0
Other net income (expense)	-13.81%-11.81M	-10.3M	-1.61M	1.4M	282K	-10.38M
Gain on sale of security	-13.81%-11.81M	---10.3M	---1.61M	--1.4M	--282K	---10.38M	----	----	----	----
Income before tax	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Income tax
Net income	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Net income continuous Operations	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Minority interest income
Net income attributable to the parent company	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Preferred stock dividends	8.33%208K	867K	0	72K	603K	192K
Other preferred stock dividends
Net income attributable to common stockholders	-43.37%-21.17M	-73.95%-31.41M	-46.36%-7.8M	20.73%-4.41M	-22.14%-4.44M	-317.50%-14.77M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Basic earnings per share	37.11%-0.61	-6.67%-1.28	54.29%-0.16	64.86%-0.13	-20.83%-0.29	-304.17%-0.97	-39.53%-1.2	-105.88%-0.35	0.00%-0.37	-205.03%-0.24
Diluted earnings per share	37.11%-0.61	-6.67%-1.28	54.29%-0.16	64.86%-0.13	-20.83%-0.29	-304.17%-0.97	-39.53%-1.2	-105.88%-0.35	0.00%-0.37	-205.03%-0.24
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall